1 study on APELIN-13(MOD) curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This study provides compelling evidence that modified C-terminal apelin fragments possess significant cardiometabolic and antioxidant properties, offering a novel therapeutic avenue for treating cardiac pathologies. T…
Free, no account — handy when you're working with APELIN-13(MOD).